Wall Street plunges on fears of coronavirus pandemic
Send a link to a friend
[February 25, 2020] By
Sinéad Carew
New York (Reuters) - The S&P 500 and the
Dow Jones Industrial Average on Monday suffered their biggest one-day
percentage losses in two years after a surge in coronavirus cases
outside China fanned worries about the global economic impact of a
potential pandemic.
Investors sold riskier assets and rushed to traditionally safer bets
such as gold and U.S. Treasuries after countries including Iran, Italy
and South Korea reported a rise in virus cases over the weekend even as
China eased curbs with no new cases reported in Beijing and other
cities.
The benchmark S&P 500, which represents over 44% of the market
capitalization of all global equities, lost $927 billion of its value on
Monday alone and $1.33 trillion since its closing high on Wednesday last
week, according to S&P Dow Jones Indices senior analyst Howard
Silverblatt.
The S&P and the blue-chip Dow turned negative for the year to date and
the Dow dropped more than 1,000 points on the day for only the third
time in its history.
The technology-heavy Nasdaq fell 3.71%, the biggest daily percentage
drop of the three major averages.
"We're not likely to make any progress higher until we have evidence the
spread of the coronavirus is decelerating," said Mark Luschini, chief
investment strategist at Janney Montgomery Scott in Philadelphia.
The Dow Jones Industrial Average fell 1,031.61 points, or 3.56%, to
27,960.8, the S&P 500 lost 111.86 points, or 3.35%, to 3,225.89 and the
Nasdaq Composite dropped 355.31 points, or 3.71%, to 9,221.28.All of the
11 major S&P sectors closed in the red, led by the energy sector's 4.7%
decline and followed by a 4.2% drop in technology stocks.
Apple Inc slid 4.8% as data showed sales of smartphones in China tumbled
by more than a third in January.
China-exposed chipmakers fell, with the Philadelphia SE Semiconductor
index dropping 4.8%, while concerns about growing travel curbs dragged
the NYSE Arca Airline Index down 6%.
Of the S&P's sectors, the defensive utilities, real estate and consumer
staples indexes fell the least on the day.
Treasury yields fell to their lowest levels since 2016 as investors
sought safety in government bonds, while the yield curve inversion
between the 3-month and 10-year U.S. Treasuries deepened in what is
often viewed as a recession predictor.
Adding to worries, Goldman Sachs slashed its U.S. growth forecast on
Sunday and predicted a more severe impact from the epidemic. [US/]
The CBOE Volatility Index, a gauge of investor anxiety, registered its
biggest one-day jump since February 2018 and ended the day at 25.03, its
highest closing level since January 2019.
[to top of second column] |
Traders work on the floor at the New York Stock Exchange (NYSE) in
New York, U.S., February 24, 2020. REUTERS/Brendan McDermid
"There was this underlying concern that was out there, and obviously over the
weekend, it just escalated," said Stacey Gilbert, portfolio manager for
derivatives at Glenmede Investment Management in Philadelphia.
After Monday's nosedive, the S&P closed almost 5% below its record closing high,
achieved last week, while the Nasdaq ended 6% off its peak close and the Dow
ended the day 5.4% below its record close.
(GRAPHIC: Coronavirus timeline -
https://graphics.reuters.com/
USA-STOCKS/0100B5FM3PJ/
coronavirus-timeline.png)
The S&P 500 fell below its 50-day moving average and the Dow slipped below its
100-day moving average, all closely watched technical indicators.
Health insurers such as UnitedHealth Group Inc and Cigna Corp dropped almost 8%
after Senator Bernie Sanders, who backs the elimination of private health
insurance, strengthened his position for the Democratic presidential nomination
with a victory in the Nevada caucuses.
Janney Montgomery Scott's Luschini said that while the coronavirus was "by far
and away the primary influence" for the market's decline on Monday, investors,
he said, were "also beginning to handicap the odds of Sanders being the
Democratic nominee."
In a rare bright spot, Gilead Sciences Inc, whose antiviral remdesivir has shown
promise in monkeys infected by a related coronavirus, rose 4.6%.
Declining issues outnumbered advancing ones on the NYSE by a 6.74-to-1 ratio; on
Nasdaq, a 6.02-to-1 ratio favored decliners.
The S&P 500 posted seven new 52-week highs and 23 new lows; the Nasdaq Composite
recorded 21 new highs and 154 new lows.
On U.S. exchanges, 10.59 billion shares changed hands, compared with the 7.79
billion average for the last 20 sessions.
(GRAPHIC: S&P 500 industry sectors -
https://fingfx.thomsonreuters.com/
gfx/ce/7/8679/8660/Pasted%20Image.jpg)
(Additional reporting by Lewis Krauskopf, April Joyner, and Stephen Culp in New
York and Medha Singh in Bengaluru; Editing by Arun Koyyur, Chizu Nomiyama and
Dan Grebler)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |